Skip to main content

Table 1 Baseline characteristics of AVPM patients by treatment group

From: Neuro-ophthalmologic outcomes of standard versus hypo-fractionated stereotactic radiotherapy of AVPM

Characteristic Treatment group   p-value
  cFSRT (n = 35) hSRT (n = 13)  
MRI Findings before treatment    
 Optic nerve sheath involved (including ONSM)/Not involved 22/13 (63%/37%) 6/7 (46%/54%) 0.297
 Multiple masses 6 (18%) 1 (8%) 0.655
 Radiographic laterality of tumor (right side) 16 (46%) 6 (46%) 0.978
Histopathologic classification (WHO Grade)    
WHO Grade    
 Unknown 9 (56%) 4 (40%) 0.840
  I 6 (38%) 5 (50%)  
  II 1 (6%) 1 (10%)  
  III 0 (0%) 0 (0%)  
  1. AVPM anterior visual pathway meningioma; hSRT hypofractionated stereotactic radiotherapy; cFSRT conventionally fractionated stereotactic radiotherapy; inv. involvement; ONSM optic nerve sheath meningioma. WHO world health organization